In Vitro Effects of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (RhGM-CSF) on Polymorphonuclear Cell (PMN) and Monocyte (MO) Functional Capacities in Ovarian Cancer Patients Versus Human Volunteers

References

• Pistoia V. The biology of haemopoietic growth factors. Trends Exp. Clin. Med. 1992; 2: 155
   Google Scholar
• Grant S. M., Heel R. C. Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF). Drugs 1992; 43: 516
   PubMed Web of Science ®Google Scholar
• Sieff C. A. Hematopoietic growth factors. J. Clin. Invest. 1987; 79: 1549
   PubMed Web of Science ®Google Scholar
• Groopman J. E., Molina J. M., Scadden D. T. Hematopoietic growth factors. Biology and clinical applications. N. Engl. J. Med. 1989; 321: 1449
   PubMed Web of Science ®Google Scholar
• Harmenberg J., Höglund M., Hellstrom-Lindberg E. G-and GM-CSF in oncology and oncological haematology. Eur. J. Haematol. 1994; 52: 1
   PubMed Web of Science ®Google Scholar
• Huebner K., Isobe M., Croce C. M., et al. The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q-anomaly. Science 1985; 230: 1282
   PubMed Web of Science ®Google Scholar
• Metcalf D., Begley C. G., Johnson G. R., et al. Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1986; 67: 37
   PubMed Web of Science ®Google Scholar
• Dexter T. M., Fairbairn L. J. The molecular control of hematopoiesis. Anti-Cancer Drugs 1993; 4: 5
   Google Scholar
• Weisbart R. H., Golde D. W., Gasson J. C. Biosynthetic human GM-CSF modulated the number and affinity of neutrophil f-Met-Leu-Phe receptors. J. Immunol. 1986; 137: 3584
   PubMed Web of Science ®Google Scholar
• Gasson J. C., Weisbart R. H., Kaufman S. E., et al. Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science 1984; 226: 1339
   PubMed Web of Science ®Google Scholar
• Jones T. C. The effects of rhGM-CSF on macrophage function. Eur. J. Cancer 1993; 29A: 10S, (suppl 3)
   Google Scholar
• Bober L. R., Grace M. J., Pugliese-Sivo C., et al. The effect of GM-CSF and G-CSF on human neutrophil function. Immunopharmacology 1995; 29: 111
   PubMed Web of Science ®Google Scholar
• Wiltschke C., Kratner M., Nanut M., et al. In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity. J. Interf. Cytok. Res. 1995; 15: 249
   PubMed Web of Science ®Google Scholar
• Tortorella C., Polignano A., Piazzolla G., et al. Lipopolysaccharide, granulocyte-monocyte colony-stimulating factor and pentoxifylline-mediated effects on formyl-methionyl-leucine-phenylalanine-stimulated neutrophil respiratory burst in the elderly. Microbios 1996; 85: 189
   PubMedGoogle Scholar
• Masucci G., Wersall P., Ragnhammar P., et al. Granulocyte-macrophage colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity. Cancer Immunol. Immunother. 1989; 29: 288
   PubMed Web of Science ®Google Scholar
• Rapaport A. P., Abboud C. N., Di Persio J. F. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation. Blood Rev 1992; 6: 43
   Google Scholar
• Antman K. GM-CSF in marrow transplantation. Eur. J. Cancer 1993; 29A: 2S, (suppl 3)
   Google Scholar
• Lieschke G. J., Burgess A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N. Engl. J. Med. 1992; 327: 99
   PubMed Web of Science ®Google Scholar
• Cuffie C. A., Schuster M. W., Larson R. A., et al. Leucomax in myelodysplastic syndrome and aplastic anaemia: results of a randomized multicentre trial. Leucomax: Current Use and Future Applications. Lucerne. 1993; 15
   Google Scholar
• Gianni A. M., Bregni M., Siena S., et al. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J. Clin. Oncol. 1990; 8: 768
   PubMed Web of Science ®Google Scholar
• Hill A. D.K., Redmond H. P., Bouchier-Hayes D. Granulocyte-Macrophages Colony-Stimulating Factor inhibits tumor growth during the postoperative period. Surgery 1996; 119: 178
   Google Scholar
• de Vries E. G.E., Biemsa B., Willemse P. H.B., et al. A double-bind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemoterapy for ovarian carcinoma. Cancer Res. 1991; 51: 116
   PubMed Web of Science ®Google Scholar
• Ochiai K., Terashima Y. Chemotherapy and granulocyte colony-stimulating factor in ovarian cancer. Semin. Oncol. 1994; 21: 23, (suppl 1)
   PubMed Web of Science ®Google Scholar
• Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Lab. Invest. 1968; 21: 77
   PubMed Web of Science ®Google Scholar
• Mandell G. L., Hook E. W. Leukocyte function in chronic granulomatous disease of childhood. Am. J. Med. 1969; 47: 473
   PubMed Web of Science ®Google Scholar
• Haston W. S., Shields J. M. Neutrophil leukocyte chemotaxis: a simplified assay for measuring polarizing responses to chemotactic factors. J. Immunol. Meth. 1985; 81: 229
   PubMed Web of Science ®Google Scholar
• Jirillo E., Miragliotta G., Caretto G., et al. Relationship between immune system and Gram-negative bacteria. Acid-treated Salmonella minnesota R595(Re) enhances immune responsiveness in patients with gynaecologic malignancies. Int. J. Immunopharmac. 1986; 8: 881
   Google Scholar
• Phillips N., Jacobs S., Stoller R., et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma. Blood 1989; 74: 26
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S., Buescher S., Le Maistre A., et al. Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1988; 72: 134
   PubMed Web of Science ®Google Scholar
• Fleischmann J., Golde D. W., Weisbart R., et al. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 1986; 68: 708
   PubMed Web of Science ®Google Scholar
• Fabian I., Baldwin G. C., Golde D. W. Biosynthetic granulocyte-macrophage colony stimulating factor enhances neutrophil cytotoxicity toward human leukemia cells. Leukemia 1987; 1: 613
   PubMed Web of Science ®Google Scholar